Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
(TSV:
ZYUS
)
1.000
UNCHANGED
Streaming Delayed Price
Updated: 10:00 AM EDT, May 2, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
1.000
Bid (Size)
1.020 (4)
Ask (Size)
1.060 (5)
Prev. Close
1.000
Today's Range
1.000 - 1.000
52wk Range
0.7100 - 1.120
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
ZYUS Life Sciences Receives United States Patent No. 11,963,943 Covering Pain Management
April 23, 2024
From
ZYUS Life Sciences Corporation
Via
Business Wire
Top Cannabis Appointments You Should Know About: Aurora's New CFO And Other Changes
February 20, 2024
Cannabis multi-state operator Cresco Labs kicked off February by announcing the promotion of Greg Butler to the position of president. Tom Shuman, a CPG sales and marketing veteran, agreed to serve as...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Performance
YTD
+12.36%
+12.36%
1 Month
-4.76%
-4.76%
3 Month
+1.01%
+1.01%
6 Month
+17.65%
+17.65%
1 Year
-3.85%
-3.85%
More News
Read More
ZYUS Strengthens Expertise of Clinical Advisory Committee with the Appointment of Dr. Hance Clarke
February 01, 2024
From
ZYUS Life Sciences Corporation
Via
Business Wire
ZYUS Strengthens Leadership Team with Appointment of Vice President of Clinical Research
January 09, 2024
From
ZYUS Life Sciences Corporation
Via
Business Wire
ZYUS Life Sciences Corporation Announces Phase 2 Clinical Trial Evaluating Trichomylin® Softgel Capsules for Advanced Cancer Pain Management
December 05, 2023
From
ZYUS Life Sciences Corporation
Via
Business Wire
ZYUS Life Sciences Corporation Announces Positive Phase I Clinical Trial Results for Trichomylin® Softgels
November 21, 2023
From
ZYUS Life Sciences Corporation
Via
Business Wire
ZYUS Life Sciences Corporation Announces New Director of Investor Relations and Capital Markets
October 24, 2023
From
ZYUS Life Sciences Corporation
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.